These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Controversies in urologic oncology. Dreicer R; See W; Williams R Iowa Med; 1991 Aug; 81(8):343-5. PubMed ID: 1938300 [No Abstract] [Full Text] [Related]
5. [New therapies for urologic cancer diseases. The Danish Society of Urology]. Lund L; Borre M; Hermann GG; Svolgaard N; Ugeskr Laeger; 2008 Mar; 170(12):1057. PubMed ID: 18397675 [No Abstract] [Full Text] [Related]
6. [Update urooncology: news with clinical relevance from major scientific meetings 2012]. Hegele A; Skrobek L; Schrader AJ Aktuelle Urol; 2012 Dec; 43(6):376-87. PubMed ID: 23254351 [TBL] [Abstract][Full Text] [Related]
7. Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer. Azumi M; Kobayashi H; Aoki N; Sato K; Kimura S; Kakizaki H; Tateno M J Urol; 2010 May; 183(5):2036-44. PubMed ID: 20303532 [TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibodies against the kidney and kidney neoplasms: potential diagnostic probes and therapy]. Scherberich JE; Fischer P; Karich HJ; Schoeppe W Immun Infekt; 1989 Feb; 17(1):29-30. PubMed ID: 2466766 [TBL] [Abstract][Full Text] [Related]
9. New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer. Chlosta PL; Golabek T; Nyirády P Biomed Res Int; 2017; 2017():6467072. PubMed ID: 28386561 [No Abstract] [Full Text] [Related]
10. [An 18-year follow-up of a patient with four asynchronous malignant tumors of the urogenital system]. Alferov SM; Grishin MA; Odintsov SV; Chuprik-Malinovskaia TP Urologiia; 2014; (1):68-72. PubMed ID: 24772778 [No Abstract] [Full Text] [Related]
11. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients. Marten-Perolino R; Cocimano V; Botto A; Buffa G; Riggi E; Trapani C J Exp Pathol; 1987; 3(4):587-92. PubMed ID: 3454806 [No Abstract] [Full Text] [Related]
12. Next revolution in molecular theranostics: personalized medicine for urologic cancers. Aoun F; Kourie HR; Artigas C; Roumeguère T Future Oncol; 2015; 11(15):2205-19. PubMed ID: 26235183 [TBL] [Abstract][Full Text] [Related]
13. Prostatic and bladder cancer in the elderly. Gaddipati J; Ahmed T; Friedland M Clin Geriatr Med; 1987 Nov; 3(4):649-67. PubMed ID: 3315161 [TBL] [Abstract][Full Text] [Related]
15. [News with clinical relevance from major scientific meetings 2014 - Update Urooncology]. Hegele A; Skrobek L; Boegemann M Aktuelle Urol; 2015 Mar; 46(2):106-17. PubMed ID: 25909966 [TBL] [Abstract][Full Text] [Related]
16. [Urogenital cancer]. Koiso K; Rinsho K; Nemoto R; Ishikawa H; Ohtani M; Uchida K; Noguchi R Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):971-7. PubMed ID: 2658819 [TBL] [Abstract][Full Text] [Related]
17. Molecular and immunologic approaches in the management of bladder cancer. Fradet Y Urol Clin North Am; 1991 Aug; 18(3):515-24. PubMed ID: 1877114 [TBL] [Abstract][Full Text] [Related]
18. [A case of synchronous triple primary cancers of prostate, kidney and bladder]. Harima M; Narita K; Kobayakawa H; Tsujino T; Yamamoto S; Fukushima S; Kishimoto T Hinyokika Kiyo; 1998 Sep; 44(9):675-8. PubMed ID: 9805676 [TBL] [Abstract][Full Text] [Related]